Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1272 |
---|---|
Product Name | Anti-Clostridium Difficile Toxin A Recombinant Antibody |
Molecular Name | Actoxumab |
Alias | Anti-Toxin A Recombinant Antibody, Research Grade Actoxumab |
CAS Number | 1245634-25-6 |
Target | Toxin A[Clostridium difficile] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | FuncS, IF, Neut, ELISA, FCM, IP, WB |
Buffer | PBS, pH7.5 |
Background | Actoxumab is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficile infection. This drug, along with bezlotoxumab, was developed through Phase II efficacy trials by a partnership between Medarex Inc and MassBiologics of the University of Massachusetts Medical School. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |